Results 111 to 120 of about 5,545,002 (288)

New Oncologic Drugs from 2008 to 2023—Differences in Approval and Access between the United States, Europe and Brazil

open access: yesCurrent Oncology
Introduction: Advancements in oncology have revolutionized cancer treatment, with new drugs being approved at different rates worldwide. Our objective was to evaluate the approval of new oncological drugs for solid tumors by the Food and Drug ...
Rafael Balsini Barreto   +2 more
doaj   +1 more source

DRUG LAG FOR ANTIMICROBIAL AGENTS: COMPARISON OF THE US, EU AND INDIA APPROVALS

open access: yesNational Journal of Medical Research, 2012
Background: Antimicrobial resistance is a global problem and the need for new antimicrobial agents is greater in both developed and developing nations.
Bhaven C Kataria   +2 more
doaj  

Comparing cancer drug approval systems in the United States and Japan. [PDF]

open access: yesHealth Sci Rep, 2023
Kaneda Y   +4 more
europepmc   +1 more source

FDA New Drug Approval Times, Prescription Drug User Fees, and R & D Spending [PDF]

open access: yes
FDA-approval times have declined significantly since the enactment of the Prescription Drug User Fee Act (PDUFA) in 1992. As a result, present value expected returns to pharmaceutical R&D have likely increased.
Golec, Joseph H.   +3 more
core   +1 more source

Strong Support For Sununu, Drugs Remain Most Important Problem Facing NH 5/9/17 [PDF]

open access: yes, 2017
Governor Chris Sununu enjoys bipartisan approval of his job performance as well as increasing personal favorability among New Hampshire adults. A strong majority continue to believe overall the state is headed in the right direction, but for the first ...
Survey Center, UNH
core   +1 more source

Home - About - Disclaimer - Privacy